Seqens Seqens

X

List of Certificates of Suitability (CEPs) for Rivaroxaban Active Pharmaceutical Ingredient issued by the EDQM and listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

Flag India
Digital Content Digital Content
R0-CEP 2021-045 - Rev 00
Valid
Chemical
2023-06-23
2932
Flag India
Digital Content Digital Content
R0-CEP 2021-277 - Rev 01
Valid
Chemical
2023-08-07
2932
Megafine Pharma CB

Iran Expo

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-238 - Rev 00
Valid
Chemical
2023-04-12
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-376 - Rev 00
Valid
Chemical
2022-12-15
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Germany
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-090 - Rev 00
Valid
Chemical
2023-02-22
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2022-144 - Rev 00
Valid
Chemical
2023-07-20
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2022-314 - Rev 00
Valid
Chemical
2023-08-04
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-252 - Rev 00
Valid
Chemical
2022-09-12
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-278 - Rev 00
Valid
Chemical
2023-03-06
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag South Korea
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-211 - Rev 00
Valid
Chemical
2023-08-21
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-029 - Rev 00
Valid
Chemical
2022-03-28
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2022-159 - Rev 00
Valid
Chemical
2023-06-26
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-185 - Rev 00
Valid
Chemical
2023-01-17
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-178 - Rev 00
Valid
Chemical
2022-09-06
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
CEP 2021-047 - Rev 01
Valid
Chemical
2023-09-28
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Slovenia
Digital Content Digital Content
URL Supplier Web Content
CEP 2021-231 - Rev 01
Valid
Chemical
2023-11-07
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Slovenia
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-232 - Rev 01
Valid
Chemical
2023-05-11
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-318 - Rev 01
Valid
Chemical
2022-12-19
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-369 - Rev 00
Valid
Chemical
2023-01-16
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-028 - Rev 00
Valid
Chemical
2023-02-24
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-201 - Rev 00
Valid
Chemical
2022-10-19
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Spain
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-405 - Rev 00
Valid
Chemical
2021-07-30
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
CEP 2021-466 - Rev 01
Valid
Chemical
2023-09-14
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-091 - Rev 00
Valid
Chemical
2023-07-21
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Israel
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-036 - Rev 00
Valid
Chemical
2023-06-16
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
CEP 2021-259 - Rev 01
Valid
Chemical
2023-12-18
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-274 - Rev 00
Valid
Chemical
2021-12-09
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-389 - Rev 00
Valid
Chemical
2023-06-12
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-017 - Rev 00
Valid
Chemical
2022-02-17
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
CEP 2020-327 - Rev 01
Valid
Chemical
2024-01-11
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-142 - Rev 00
Valid
Chemical
2022-11-17
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2021-050 - Rev 00
Valid
Chemical
2023-06-19
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-330 - Rev 01
Valid
Chemical
2023-03-23
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 366789-02-8 / Rivaroxaban API manufacturers, exporters & distributors?

Rivaroxaban manufacturers, exporters & distributors 1

79

PharmaCompass offers a list of Rivaroxaban API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rivaroxaban manufacturer or Rivaroxaban supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rivaroxaban manufacturer or Rivaroxaban supplier.

PharmaCompass also assists you with knowing the Rivaroxaban API Price utilized in the formulation of products. Rivaroxaban API Price is not always fixed or binding as the Rivaroxaban Price is obtained through a variety of data sources. The Rivaroxaban Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Rivaroxaban

Synonyms

366789-02-8, Xarelto, Bay 59-7939, (s)-5-chloro-n-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide, Bay59-7939, Bay-59-7939

Cas Number

366789-02-8

Unique Ingredient Identifier (UNII)

9NDF7JZ4M3

About Rivaroxaban

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Rivaroxaban Manufacturers

A Rivaroxaban manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rivaroxaban, including repackagers and relabelers. The FDA regulates Rivaroxaban manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rivaroxaban API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Rivaroxaban manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Rivaroxaban Suppliers

A Rivaroxaban supplier is an individual or a company that provides Rivaroxaban active pharmaceutical ingredient (API) or Rivaroxaban finished formulations upon request. The Rivaroxaban suppliers may include Rivaroxaban API manufacturers, exporters, distributors and traders.

click here to find a list of Rivaroxaban suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Rivaroxaban CEP

A Rivaroxaban CEP of the European Pharmacopoeia monograph is often referred to as a Rivaroxaban Certificate of Suitability (COS). The purpose of a Rivaroxaban CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rivaroxaban EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rivaroxaban to their clients by showing that a Rivaroxaban CEP has been issued for it. The manufacturer submits a Rivaroxaban CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rivaroxaban CEP holder for the record. Additionally, the data presented in the Rivaroxaban CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rivaroxaban DMF.

A Rivaroxaban CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rivaroxaban CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Rivaroxaban suppliers with CEP (COS) on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY